Skip to main content
Main menu
Pipeline
Clinical
Discovery
Compounds
Regimens
Drug Targets
Developers
Trial Sites
Trials
News
Meetings
Members
Our Members
Core Group
About
Join Us
Drug Target
DPRE1 Noncovalent Inhibitors
Compound Associations
Phase 2. Early Bactericidal Activity of TBA-7371 in Pulmonary Tuberculosis
Phase 2. Early Bactericidal Activity of TBA-7371 in Pulmonary Tuberculosis
Phase 2b/c. 4-month Regimen of OPC-167832, Delamanid and Bedaquiline for DS Pulmonary TB
Phase 1 Study to Evaluate Safety, Tolerability, PK, and PK Interactions of TBA-7371
TBA-7371
Description